click below
click below
Normal Size Small Size show me how
Glaucoma Info
Question | Answer |
---|---|
Glaucoma | ocular diseases resulting in increased IOP |
Patho | increased IOP reduces blood flow to optic nerve & retina |
Primary glaucoma (causes) | aging, genes, central retinal vein occlusion |
Secondary glaucoma (causes) | Uveitis, iritis, neovascular disorder, trauma, ocular tumor, degenerative disease, eye surgery |
Associated glaucoma (causes) | DM, HTN, severe myopia, retinal detachment |
Open-angle glaucoma | gradual increase in IOP/decrease in visual fields |
Open-angle patho | fluid cannot leave the eyes at same rate it’s produced |
Angle-closure glaucoma | sudden onset, EMERGENCY |
Angle-closure patho | narrowed angle & forward displacement of iris onto cornea; narrows/closes chamber angle which obstructs fluid outflow |
S/S of emergent situation | sudden, severe pain around eyes radiating over face; NV; headache/brow px |
Early glaucoma s/s | increased IOP, diminished accommodation |
Late glaucoma s/s | diminished visual fields, decreased acuity (glasses ineffective), halos, headache, eye px (acute), increased cup-disc ratio, pale optic disc |
Opthalmoscopic results | Shallow anterior chamber; Cloudy aqueous humor; Moderately dilated/non-reactive pupil |
Tonometry | Measures IOP; closed-angle >30mmHg; open-angle 22-32mmHg |
Tonography | Outflow measured w/ weight on globe; Normal-steep downward tracing; Glaucoma-flat tracing |
Gonioscopy | helps view drainage angle in anterior chamber; entire 360 circumference is viewed |
Non-surgical management | focus on prevention & early detection, topical agents to reduce ocular HTN can delay/prevent damage |
Drug therapy goals | reduce IOP by (1) improve flow of AH to absorption site, (2) reduce production of AH |
Pilocarpine - Class | Direct-acting cholinergic; Miotic |
Pilocarpine - Action | Constrict pupils and contract ciliary muscle |
Direct-acting cholinergic teaching | vision may be blurry for 1-2 hours; low-light vision can be diminished; report s/s of systemic effects |
Timoptic (timolol) - Class | beta-blocker |
Timoptic (timolol) - Action | decrease IOP by reducing AH production w/o pupillary constriction |
Diamox (acetazolamide) - Class | carbonic anhydrase inhibitor |
Diamox (acetazolamide) - Action | maintains low IOP by reducing AH production |
Propine (dipivefrin HCl) - Class | Sympathomimetic |
Propine (dipivefrin HCl) - Action | decrease production of AH which decreases IOP (converted to epi in eye) |
Propine (dipivefrin HCl) - Contraindication | Angle-closure glaucoma b/c it dilates pupil |
Surgical management | laser surgery, standard surgical procedure |
Laser surgery (indication) | open-angle glaucoma refractory to meds & angle-closure glaucoma |
Laser for Open-angle (procedure) | laser burns trabecular meshwork, causing fibers to tighten, increasing intra-fiber space, resulting in improved outflow |
Laser for Angle-Closure (procedure) | laser creates hole near edge of iris, allowing AH to flow from posterior chamber to anterior chamber to drainage meshwork |
Laser Pre-op care | inform pt about procedure, expected sights/sounds, expected outcomes |
Laser Post-op care | pt needs a driver, re-eval IOP 1 hr post-procedure & before discharge, ocular steroid may be prescribed |
Standard surgery (indications) | open-angle refractory to meds & laser; angle-closure (some cases) |
Standard procedure | creation of new drainage channel or destruction of production structures; followed by antibiotic injection under conjunctiva & eye-patch |
Standard Post-op Teaching | No ASA, avoid lying on operative side, report brow px/severe eye px/nausea |
Standard Complication | choroidal hemorrhage (S/S acute deep eye px, decreased vision, changes in VS) |